HIV inhibiting 1,2,4-triazin-6-one derivatives

Details for Australian Patent Application No. 2005271161 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors De Jonge, Marc Rene; Vinkers, Hendrik Maarten; Kilonda, Amuri; Heeres, Jan; Hoornaert, Georges Joseph Cornelius; Janssen, Paul Adriaan Jan; Lewi, Paulus Joannes; Koymans, Lucien Maria Henricus; Daeyaert, Frederik Frans Desire

Agent Shelston IP

Pub. Number AU-B-2005271161

PCT Pub. Number WO2006/015985

Priority 04103858.9 10.08.04 EP

Filing date 10 August 2005

Wipo publication date 16 February 2006

Acceptance publication date 12 May 2011

International Classifications

C07D 253/06 (2006.01) Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/015985 Priority application(s): WO2006/015985

12 May 2011 Application Accepted

  Published as AU-B-2005271161

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005271162-Mercaptoimidazoles as CCR2 receptor antagonists

2005271158-Method of making vapour deposited oxygen-scavenging particles